Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 31;10(1):2365125.
doi: 10.1080/20565623.2024.2365125. Epub 2024 Aug 25.

Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis

Affiliations
Review

Evaluating the impact of testosterone replacement therapy on carotid atherosclerosis: a systematic review and meta-analysis

Syed Hamza Haider et al. Future Sci OA. .

Abstract

Aim: This meta-analysis investigates the association between testosterone replacement therapy [TRT] and carotid artery atherosclerosis. Methods: 3 databases were searched for studies up to June 2023 per the PRISMA guidelines. The eligibility criteria comprised RCTs and observational studies involving hypogonadal males receiving exogenous testosterone, in which CIMT was assessed. CAA was the primary outcome, whereas secondary outcomes included HDL, LDL, CRP, total cholesterol and total testosterone. The statistical analysis was performed using Review Manager. Results: Statistical analysis revealed no association between TRT and assessed outcomes. There was a significant increase in total testosterone levels, depicting indirect anti-atherosclerotic effects of TRT. Conclusion: Meta-analysis shows no relation between TRT and CIMT or other markers, allowing its safe usage for hypogonadal males.

Keywords: atherosclerosis; carotid artery; carotid intima media thickness; exogenous testosterone; hormone replacement therapy; hypogonadal males; inflammatory markers; lipid markers; meta-analysis; testosterone replacement therapy.

Plain language summary

[Box: see text].

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Figures

Figure 1.
Figure 1.
Forest Plot of CIMT.
Figure 2.
Figure 2.
Forest Plot of HDL.
Figure 3.
Figure 3.
Forest Plot of LDL.
Figure 4.
Figure 4.
Forest plot of CRP.
Figure 5.
Figure 5.
Forest plot of total cholesterol.
Figure 6.
Figure 6.
Forest plot of total testosterone.

References

    1. Jagannathan R, Patel SA, Ali MK, et al. . Global updates on CVS disease mortality trends and attribution of traditional risk factors. Curr Diabetes Rep. 2019;19(7):44. doi:10.1007/s11892-019-1161-2 - DOI - PubMed
    2. •• Provides global updates on cardiovascular disease mortality trends and the attribution of traditional risk factors, offering essential context for understanding the broader implications of cardiovascular health in the population.

    1. Martinez E, Martorell J, Riambau VJJoVS. Review of serum biomarkers in carotid atherosclerosis. J Vasc Surg. 2020;71(1):329–341. doi:10.1016/j.jvs.2019.04.488 - DOI - PubMed
    2. •• Examines serum biomarkers associated with carotid atherosclerosis, offering insights into potential indicators for disease progression or risk assessment.

    1. Romero JR, Beiser A, Seshadri S, et al. . Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke. 2009;40(5):1590–1596. doi:10.1161/STROKEAHA.108.535245 - DOI - PMC - PubMed
    1. Prati P, Vanuzzo D, Casaroli M, et al. . Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23(12):1705–1711. doi:10.1161/01.STR.23.12.1705 - DOI - PubMed
    2. •• Investigates the prevalence and determinants of carotid atherosclerosis in a general population, providing foundational knowledge for understanding the epidemiology and risk factors associated with the condition.

    1. Rastrelli G, Guaraldi F, Reismann Y, et al. . Testosterone replacement therapy for sexual symptoms. Sex Med Rev. 2019;7(3):464–475. doi:10.1016/j.sxmr.2018.11.005 - DOI - PubMed